Cases

GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) have revolutionized weight management, initially approved for individuals with obesity (BMI ≥30) or overweight with comorbidities (BMI ≥27). However, demand has surged among individuals with normal BMI (18.5–24.9) seeking aesthetic or performance-related weight loss. Clinicians report increasing off-label requests, while shortages affect patients with diabetes or obesity who rely on these medications for health, not aesthetics. Ethical concerns include medicalization of normal weight, equity in access, and unknown long-term risks in metabolically healthy individuals. Regulatory bodies like the FDA have not approved these drugs for non-obese use, yet telehealth platforms sometimes prescribe them with minimal oversight. This dilemma confronts healthcare providers balancing patient autonomy, evidence-based practice, and resource stewardship.

Antibiotic-associated diarrhea (AAD), including life-threatening Clostridioides difficile infection (CDI), affects up to 30% of patients on antibiotics. Probiotics—live microorganisms intended to confer health benefits—are widely used to prevent AAD, with strains like Lactobacillus rhamnosus GG and Saccharomyces boulardii showing promise in meta-analyses. However, recent high-quality trials (e.g., the 2023 PRODUCE trial in JAMA) found no significant benefit of probiotics over placebo in preventing AAD or CDI in hospitalized adults. Concerns also exist about probiotic safety in immunocompromised patients and lack of regulation regarding strain specificity, viability, and dosing. Guidelines from IDSA/SHEA now conditionally recommend against routine probiotic use for AAD prevention. Yet many clinicians and patients continue using them based on older evidence and anecdotal success. This trial weighs evolving evidence against entrenched practice and patient expectations.

Buprenorphine is a life-saving medication for opioid use disorder (OUD), reducing overdose risk by 50% or more. Historically, federal law required an in-person visit before prescribing. During the pandemic, the DEA waived this rule, allowing telehealth initiation. In 2023, this flexibility was made permanent for DEA-registered providers, expanding access—especially in rural and underserved areas. However, concerns remain about diversion, inadequate assessment of co-occurring conditions, and lack of integrated support services in virtual-only models. Some states still impose additional restrictions. Meanwhile, overdose deaths remain at record highs, and access barriers persist. This trial examines whether the benefits of telehealth-initiated buprenorphine (increased access, reduced stigma) outweigh risks (incomplete evaluation, fragmented care) in the current addiction crisis.

Melatonin, a hormone regulating sleep-wake cycles, is widely used as an over-the-counter supplement for insomnia, jet lag, and circadian disorders. However, multiple studies—including a 2023 JAMA analysis—reveal alarming inconsistencies in actual versus labeled melatonin content, with some products containing up to 478% more than stated and others including unlisted serotonin (a potentially dangerous contaminant). Unlike pharmaceuticals, supplements aren't subject to FDA pre-market approval for safety, efficacy, or quality. While low-dose melatonin (0.3–1 mg) is effective for circadian regulation, many products contain 5–10 mg, which may cause next-day drowsiness, hormonal disruption, or dependency. Pediatric use is especially concerning, with rising ER visits linked to accidental ingestion. This trial questions whether melatonin's widespread use and documented quality issues warrant reclassification as a regulated drug or stricter supplement oversight.

In 2021, the U.S. Preventive Services Task Force (USPSTF) lowered the recommended starting age for colorectal cancer (CRC) screening from 50 to 45 due to rising incidence in younger adults. While colonoscopy is highly effective at detecting and preventing CRC through polyp removal, it carries risks (perforation, bleeding, sedation complications) and high costs. Alternative screening methods like stool-based tests (FIT, mt-sDNA) are less invasive and cheaper but require follow-up colonoscopy if positive. Recent data show CRC rates are indeed increasing in 45–49-year-olds, though absolute risk remains low (~0.1–0.2% over 5 years). Critics argue the new guideline may lead to over-screening, especially without risk stratification, while proponents stress early detection saves lives in a preventable cancer. This trial examines whether the benefits of universal colonoscopy at 45 outweigh harms and resource implications compared to risk-adapted or non-invasive strategies.

Artificial intelligence tools offering relationship advice—such as AI chatbots trained on therapeutic principles—are increasingly marketed to couples experiencing communication breakdowns. Platforms like Replika, Woebot, and newer couples-focused apps claim to guide users through evidence-based conflict resolution techniques drawn from CBT, Gottman principles, and attachment theory. Proponents argue these tools increase accessibility to therapeutic support, especially for those who cannot afford or access licensed professionals. Critics, however, warn that AI lacks contextual understanding of nuanced emotional dynamics, may reinforce maladaptive patterns, and cannot ethically manage high-risk situations like domestic abuse or severe mental health crises. Recent studies (e.g., 2025 Journal of Couple & Relationship Therapy meta-analysis) show mixed outcomes: while some users report improved communication skills, others experience increased anxiety or misinterpretation of partner intent. With AI relationship tools projected to reach $1.2B in market value by 2027 (Grand View Research, 2026), the question arises: should couples integrate AI coaches into their conflict resolution toolkit, or does this risk undermining genuine therapeutic progress and emotional attunement?

Gray divorce—the dissolution of marriages among adults aged 50 and older—has doubled since the 1990s, with recent CDC and Pew Research data (2026) showing nearly 40% of divorces now occur in this demographic. Unlike midlife breakups often tied to infidelity or financial stress, many gray divorces cite 'growing apart,' unmet emotional needs, or delayed self-actualization. Therapists are divided: some view these separations as courageous acts of personal growth, reflecting increased life expectancy and women's financial independence. Others caution that unresolved attachment wounds, fear of aging, or avoidance of late-life intimacy challenges may masquerade as 'growth.' Notably, longitudinal studies (e.g., 2025 UCLA Aging & Relationships Project) show mixed post-divorce well-being outcomes—some report liberation and renewed purpose, while others face profound loneliness and economic hardship. With Baby Boomers redefining aging and Gen X approaching this threshold, the psychological community must examine whether gray divorce represents authentic evolution or a flight from relational depth.

Trauma bonds—intense emotional attachments formed through cycles of abuse, intermittent reinforcement, and perceived survival dependency—are increasingly recognized beyond domestic violence contexts, appearing in high-conflict friendships, family systems, and even workplace dynamics. While traditional recovery models (e.g., Judith Herman's stages) often emphasize physical separation as essential, newer trauma-informed approaches (e.g., somatic experiencing, IFS, and EFT adaptations) explore whether deeply bonded dyads can heal in situ if both parties commit to intensive therapeutic work. A 2026 case series in the Journal of Traumatic Stress documented 12 couples who, with dual individual and conjoint therapy, reduced trauma-bond behaviors over 18 months. Yet critics argue that staying risks retraumatization, especially if power imbalances persist. With social media amplifying awareness of trauma bonds—often oversimplified as 'toxic relationships'—clinicians and individuals face a nuanced question: is relational repair possible when the bond itself is forged in dysregulation?

Gary Chapman's 'Five Love Languages' framework—Words of Affirmation, Quality Time, Receiving Gifts, Acts of Service, and Physical Touch—remains wildly popular, with over 20 million copies sold and integration into couples therapy, dating apps, and workplace wellness programs. However, recent psychological research questions its empirical foundation. A 2025 meta-analysis in Personality and Social Psychology Review found no robust evidence that matching love languages predicts relationship satisfaction beyond general communication quality. Critics argue the model lacks reliability (test-retest scores are low), cultural validity (developed in a Western, Christian context), and ignores attachment and neurobiological factors. Defenders counter that its value lies in its simplicity—it gives couples a shared vocabulary to discuss emotional needs, even if not scientifically rigorous. With TikTok and Instagram fueling its resurgence among Gen Z couples, the field must decide: is the love languages framework a helpful heuristic or a misleading oversimplification that distracts from deeper relational work?

In the wake of increased transparency movements in psychotherapy, some clinicians—particularly in relational and attachment-focused modalities—are considering whether to disclose their own attachment styles (e.g., 'I tend toward secure with anxious tendencies') to foster authenticity and model vulnerability. Advocates argue that judicious self-disclosure can normalize attachment struggles, reduce therapeutic power imbalances, and enhance co-regulation, especially in trauma-informed or EFT contexts. However, ethical guidelines from APA and AAMFT caution that therapist self-disclosure must serve the client's needs, not the therapist's. Critics warn that sharing personal attachment information may blur boundaries, shift focus from the client, or inadvertently burden clients with the therapist's unresolved material. A 2025 survey in Psychotherapy Networker found 68% of clients in long-term therapy valued such transparency, yet 72% of supervisors discouraged it without strict clinical justification. As attachment theory becomes mainstream, this tension between human connection and professional boundaries demands careful navigation.